Barclays PLC Cellebrite Di Ltd. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Barclays PLC holds 263,657 shares of CLBT stock, worth $6.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263,657
Previous 263,657
-0.0%
Holding current value
$6.65 Million
Previous $4.44 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CLBT
# of Institutions
185Shares Held
88.7MCall Options Held
741KPut Options Held
205K-
True Wind Capital Management, L.P.13.9MShares$349 Million87.15% of portfolio
-
Morgan Stanley New York, NY5.38MShares$136 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA4.39MShares$111 Million0.23% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL4.33MShares$109 Million22.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.5MShares$88.1 Million0.69% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $4.78B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...